Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

7704 ARTíCULOS , VIENDO DEL 7681 AL 7695

PUBMED

Understanding the links between cardiovascular disease and Parkinson's disease

Potashkin J, Huang X, Becker C, Chen H, Foltynie T, Marras C.

Mov Disord. 2020 Jan;35(1):55-74. doi: 10.1002/mds.27836. Epub 2019 Sep 4.

0

0

0

PUBMED

Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease

Parra I, Martínez I, Ramírez-García G, Tizabi Y, Mendieta L.

Neurotox Res. 2020 Jan;37(1):1-11. doi: 10.1007/s12640-019-00104-z. Epub 2019 Sep 2.

0

0

0

PUBMED

Home-based monitoring of falls using wearable sensors in Parkinson's disease

Silva de Lima AL, Smits T, Darweesh SKL, Valenti G, Milosevic M, Pijl M, Baldus H, de Vries NM, Meinders MJ, Bloem BR.

Mov Disord. 2020 Jan;35(1):109-115. doi: 10.1002/mds.27830. Epub 2019 Aug 26.

0

0

0

PUBMED

A neurophysiological investigation of anticipation to pain in Parkinson's disease

Martin SL, Jones AKP, Brown CA, Kobylecki C, Silverdale MA.

Eur J Neurosci. 2020 Jan;51(2):611-627. doi: 10.1111/ejn.14559. Epub 2019 Sep 13.

0

0

0

PUBMED

Rasagiline combined with levodopa therapy versus levodopa monotherapy for patients with Parkinson's disease: a systematic review

Jiang DQ, Wang HK, Wang Y, Li MX, Jiang LL, Wang Y.

Neurol Sci. 2020 Jan;41(1):101-109. doi: 10.1007/s10072-019-04050-8. Epub 2019 Aug 24.

0

0

0

PUBMED

Risk thresholds of levodopa dose for dyskinesia in Chinese patients with Parkinson's disease: a pilot study

Liu G, Chen H, Su D, Wang D, Zhang M, Wang X, Wang Z, Yang Y, Jiang Y, Ma H, Feng T.

Neurol Sci. 2020 Jan;41(1):111-118. doi: 10.1007/s10072-019-04043-7. Epub 2019 Aug 24.

0

0

0

PUBMED

The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease

Han QW, Yuan YH, Chen NH.

Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109745. doi: 10.1016/j.pnpbp.2019.109745. Epub 2019 Aug 20.

0

0

0

PUBMED

Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease

Jarras H, Bourque M, Poirier AA, Morissette M, Coulombe K, Di Paolo T, Soulet D.

J Neuroendocrinol. 2020 Jan;32(1):e12782. doi: 10.1111/jne.12782. Epub 2019 Sep 10.

0

0

0

PUBMED

Early Postnatal Exposure to Paraquat and Maneb in Mice Increases Nigrostriatal Dopaminergic Susceptibility to a Re-challenge with the Same Pesticides at Adulthood: Implications for Parkinson's Disease

Colle D, Santos DB, Naime AA, Gonçalves CL, Ghizoni H, Hort MA, Farina M.

Neurotox Res. 2020 Jan;37(1):210-226. doi: 10.1007/s12640-019-00097-9. Epub 2019 Aug 17.

0

0

0

PUBMED

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease

Ghadery C, Koshimori Y, Christopher L, Kim J, Rusjan P, Lang AE, Houle S, Strafella AP.

Mol Neurobiol. 2020 Jan;57(1):492-501. doi: 10.1007/s12035-019-01714-6. Epub 2019 Aug 5.

0

0

0

PUBMED

Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease

Manouchehrabadi M, Farhadi M, Azizi Z, Torkaman-Boutorabi A.

Neurotox Res. 2020 Jan;37(1):156-170. doi: 10.1007/s12640-019-00088-w. Epub 2019 Jul 30.

0

0

0

PUBMED

Distinct subthalamic coupling in the ON state describes motor performance in Parkinson's disease

Ozturk M, Abosch A, Francis D, Wu J, Jimenez-Shahed J, Ince NF.

Mov Disord. 2020 Jan;35(1):91-100. doi: 10.1002/mds.27800. Epub 2019 Jul 26.

0

0

0

PUBMED

Emergencies in an Advanced Stage Parkinson's Disease Patient

Boulas KA, Paraskeva A, Hatzigeorgiadis A.

Gastroenterology. 2020 Jan;158(1):e1-e2. doi: 10.1053/j.gastro.2019.07.023. Epub 2019 Jul 18.

0

0

0

PUBMED

Progressive brain atrophy in Parkinson's disease patients who convert to mild cognitive impairment

Zhou C, Guan XJ, Guo T, Zeng QL, Gao T, Huang PY, Xuan M, Gu QQ, Xu XJ, Zhang MM.

CNS Neurosci Ther. 2020 Jan;26(1):117-125. doi: 10.1111/cns.13188. Epub 2019 Jul 6.

0

0

0

PUBMED

Sleep in Parkinson's disease

Stefani A, Högl B.

Neuropsychopharmacology. 2020 Jan;45(1):121-128. doi: 10.1038/s41386-019-0448-y. Epub 2019 Jun 24.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy